The principle in the management of females with locally advanced breast cancer and inflammatory breast cancer is a multimodal therapy incorporating systemic treatment (chemotherapy and hormonal therapy) as well as local therapy (surgery and radiation therapy). The benefits of neoadjuvant chemotherapy over adjuvant chemotherapy is to start systemic therapy more early eliminating micrometastasis that may occur, also it results in decreased both local- regional recurrence rate and distant metastasis occurrence.